Allergy diagnostic testing in clindamycin-induced skin reactions

International Archives of Allergy and Immunology

Volumn 149, Issue 3, 2009, Pages 246-250

  Seitz, Cornelia S ^a   Bröcker, Eva B ^a   Trautmann, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Challenge test; Exanthema; Hypersensitivity; Provocation test; Skin test

Indexed keywords

CLINDAMYCIN; IMMUNOGLOBULIN E; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MALE; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SKIN ALLERGY; SKIN TEST; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CLINDAMYCIN; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN TESTS; YOUNG ADULT;

EID: 59849112632     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000199720     Document Type: Article

References (22)

1. Guay D: Update on clindamycin in the management of bacterial, fungal and protozoal infections. Expert Opin Pharmacother 2007; 8:2401-2444.
2. Kapoor R, Flynn C, Heald PW, Kapoor JR: Acute generalized exanthematous pustulosis induced by clindamycin. Arch Dermatol 2006;142:1080-1081.
3. Paquet P, Schaaf-Lafontaine N, Pierard GE: Toxic epidermal necrolysis following clindamycin treatment. Br J Dermatol 1995; 132: 665-666.
4. Mazur N, Greenberger PA, Regalado J: Clindamycin hypersensitivity appears to be rare. Ann Allergy Asthma Immunol 1999; 82: 443-445.
5. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999;83: 665-700.
6. Lammintausta K, Tokola R, Kalimo K: Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure. Br J Dermatol 2002;146:643-648.
7. Pichler WJ: Deciphering the immune pathomechanism of cutaneous drug reactions. Allergy 2002;57:34-36.
8. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al: Drug provocation testing in the diagnosis of drug hyper- sensitivity reactions: general considerations. Allergy 2003;58: 854-863.
9. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P: General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57: 45-51.
10. Trcka J, Seitz CS, Brocker EB, Gross GE, Trautmann A: Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. J Antimicrob Chemother 2007;60:107-111.
11. Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH: Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis 2005;53: 335-338.
12. Barbaud A: Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005;
13. 209:209-216.
14. Lammintausta K, Kortekangas-Savolainen O: The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-974.
15. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al: The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
16. Wynalda MA, Hutzler JM, Koets MD, Podoll T, Wienkers LC: In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metab Dispos 2003; 31: 878-887.
17. Coleman JW, Blanca M: Mechanisms of drug allergy. Immunol Today 1998;19:196-198.
18. Evans WE, McLeod HL: Pharmacogeno- mics - drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538-549.
19. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hy-persensitivity. Allergy 2004; 59: 809-820.
20. Marcos C, Sopena B, Luna I, Gonzalez R, de la Fuente J, Martinez-Vazquez C: Clindamy- cin desensitization in an AIDS patient. AIDS 1995;9:1201-1202.
21. Häusermann P, Harr T, Bircher AJ: Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004;51:297-310.
22. Shiohara T, Mizukawa Y: Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007;17:201-208.